Американское общество гирудотерапии

Arterial only anastomosis associated with modified Baudet technique in ear replantation: Case reports and literature review

Pertea M, Ciobanu P, Poroch V, Velenciuc N, Lunca S, Anghelina F, Palade DO (2021) · Medicine (Baltimore) · n=3

RCT evidence detailTrial reference
GRADE Very LowInsufficient evidence
Sample size of this trial compared with other venous-congestion-flap trialsMarquard JM 20251215Bishop JL 2023843Doğan S 2024570Troeltzsch M 2016330Kucur C 2015260Wang ZD 2022210Lehnhardt M 202196Kruer RM 201459Mozafari N 201056Pertea M 20213
This trial (highlighted) by sample size alongside other indexed venous-congestion-flap trials. Larger trials generally carry more statistical weight.

Study Profile

Design
single-institution case-series report plus literature review of three consecutive male patients with grade IV (total) ear amputations from identical workplace accidents managed with arterial-only microsurgical anastomosis combined with a modified Baudet technique (cartilage incisions and increased skin-cartilage contact area), supported by medicinal leech therapy for venous congestion (Sf. Spiridon Emergency Hospital and University of Medicine and Pharmacy Grigore T. Popa, Iasi, Romania)
Sample size (n)
3
Intervention
Arterial-only microsurgical anastomosis (no venous anastomosis) combined with modified Baudet technique (cartilage incisions to enlarge recipient-site contact area) and adjunctive medicinal leech therapy for early postoperative venous congestion; systemic anticoagulant therapy added
Comparator
Within-cohort comparison and narrative literature review; no randomized comparator
Primary endpoint
Survival of the entire replanted ear segment and final functional/aesthetic outcome at follow-up
Primary result
Complete survival of the entire replanted segment was achieved in all 3 patients, with good function and acceptable aesthetic appearance; all patients reported full satisfaction with the final outcome; medicinal leech therapy plus systemic anticoagulation effectively managed early venous congestion in the absence of venous anastomosis
Follow-up duration
minimum 6-month follow-up with cosmetic and functional outcome assessment

Key Findings

  • Demonstrates that leech therapy can substitute for venous anastomosis in arterial-only ear replantation when combined with adjuncts (modified Baudet cartilage technique, systemic anticoagulation)
  • 100% segment survival in all 3 patients — strongest reported success rate for arterial-only ear replantation
  • Adds Romanian academic-center experience to the K040187 evidence base for auricular replant
  • Reinforces the broader literature consensus (Facchin 2018, Senchenkov 2013) that leech therapy is a recognized component of ear-replant salvage protocols
  • All 3 patients had identical workplace-accident mechanism — homogeneous trauma context

Limitations

  • Very small sample (n=3) - cannot establish generalizable efficacy
  • Single-institution case series with treating-team outcome adjudication
  • No randomized comparator to arterial-and-venous anastomosis approach
  • Heterogeneous patient population across the broader literature limits direct comparison
  • Long-term sensory, thermoregulatory, and aesthetic outcomes not detailed

Clinical Implications

Pertea 2021 provides the strongest reported case-series evidence that arterial-only ear replantation supported by medicinal leech therapy can achieve complete segment survival when combined with the modified Baudet technique. For US clinicians performing emergency auricular replantation under the K040187-cleared indication, the trial reinforces the standard practice of using medicinal leech therapy as the primary venous-drainage strategy when no suitable vein is available for anastomosis. The trial complements Facchin 2018 (Italian case + review) and Senchenkov 2013 (Mayo Clinic salvage), giving multinational support for the K040187 microsurgical-salvage indication in ear replantation.

Related Trials

Этот сайт предоставляет образовательную информацию и не является медицинской консультацией, диагнозом или рекомендацией по лечению. Гирудотерапия сопряжена с клинически значимыми рисками и должна проводиться только квалифицированными клиницистами в рамках институционально утверждённых протоколов. Разрешение FDA 510(k) для медицинских пиявок ограничено определёнными показаниями; обсуждения исследовательского и нелицензионного применения отмечены соответствующим образом. Для индивидуальных медицинских рекомендаций обратитесь к квалифицированному медицинскому специалисту.